Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BIAF bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
bioAffinity Technologies said it entered a definitive agreement for a registered direct offering priced at-the-market under Nasdaq rules, with concurrent private placement warrants. The company expects gross proceeds of about $4 million before fees and expenses.
bioAffinity Technologies said it entered a definitive agreement for a registered direct offering and concurrent private placement expected to raise about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.